Table 2.
Vital signs, laboratory data, and imaging findings on admission.
| Parameter | Patients (n = 14) |
|---|---|
| Vital signs | |
| Systolic blood pressure, mmHg | 136.5 ± 24.7 |
| Diastolic blood pressure, mmHg | 76.8 ± 15.6 |
| Heart rate >100 beats per min, n (%) | 2 (14.3) |
| Respiratory rate ≥20 breaths per min, n (%) | 5 (35.7) |
| Body temperature ≥ 38 °C, n (%) | 3 (21.4) |
| Laboratory results (normal range) | |
| White blood cell count, ×103/µL (4.0–10.0) | 5.8 ± 2.1 |
| Lymphocyte count, ×103/µL (1.0–4.5) | 1.1 ± 0.5 |
| Hemoglobin, g/dL (13.0–18.0) | 10.5 ± 1.4 |
| Platelet count, ×103/µL (130–400) | 162.1 ± 74.0 |
| C-reactive protein, mg/dL (<0.5) | 6.1 (3.0–8.8) |
| Ferritin, ng/mL (n = 9; 30–400) | 472.0 (292.4–1693.2) |
| Procalcitonin, ng/mL (n = 9; <0.05) | 0.6 (0.3–1.0) |
| Albumin, g/dL (3.5–5.2) | 3.3 ± 0.7 |
| Alanine aminotransferase, U/L (<41) | 14.5 (11.5–18.0) |
| Aspartate aminotransferase, U/L (<40) | 19.0 (16.0–33.8) |
| Lactate dehydrogenase, U/L (135–250) | 264.5 (196.0–401.0) |
| Creatine phosphokinase, U/L (n = 10; 26–192) | 210.4 ± 188.8 |
| Lactic acid, mmol/L (n = 8; 0.5–1.6) | 1.3 (1.1–2.2) |
| Prothrombin time, sec (n = 12; 10–14) | 13.1 (13.0–13.9) |
| Activated partial thromboplastin time, s (n = 12; 20–35) | 37.8 (36.3–40.9) |
| D-dimer, µg/mL (n = 7; <0.5) | 1.7 (1.0–3.8) |
| Chest radiography findings, n (%) | |
| Clear | 4 (28.6) |
| Unilateral infiltration | 3 (21.4) |
| Bilateral infiltration | 7 (50.0) |
| Pleural effusion | 2 (14.3) |
Abbreviations: COVID-19, coronavirus disease 2019; IQR, interquartile range. Data are presented as means ± standard deviation, median (IQR), or n (%).